BIODETECTION MARKET ANALYSIS

Leading Companies

Key Developments

Key players in the market are focused on product development and exhibition in order to enhance their market share. For instance, in June 2019, TetraCore, Inc. presented its novel multiplex assay for detection of orthopoxvirus (OPV) at the Biodefense World Summit 2019 held at Maryland, U.S. The company developed mouse monoclonal and rabbit polyclonal antibodies to Vaccinia virus that were used to develop a novel multiplex assay for detection of OPV.

Major companies are also focused on adopting collaboration and partnership strategies for product development and marketing in order to expand their product portfolio. For instance, in May 2019, EDP Biotech Corporation entered into a non-exclusive agreement with Luminex Corporation, under which the former will have the rights to develop, market and sell its blood-based colorectal cancer diagnostic assay, ColoPlex, using Luminex's xMAP Technology.

Companies in the market are also focused on product development. For instance, in August 2019, Bio-Techne Corporation introduced Maurice Empower Control Kit for the ProteinSimple-branded Maurice platform. This new kit enables users to collect, manage, and report Maurice results with Empower 3 Software developed by Waters Corporation.